Valproic acid-induced hyperammonemia with encephalopathy in adults: A meta-analysis [0.03%]
成人丙戊酸诱导高氨血症及脑病的meta分析研究
Tsai-Kuei Huang,Yi-Chia Su,Ching-Sen Shih
Tsai-Kuei Huang
Objective: Valproic acid, frequently prescribed for neurological and psychiatric disorders, can cause hyperammonemia (HA). This retrospective study aimed to investigate the association among the basic characteristics, com...
Sodium-glucose cotransporter 2 inhibitor treatment has differential effects on the incidence of various malignancies: Evidence from a spontaneous adverse reaction database [0.03%]
钠-葡萄糖共转运体2抑制剂对各种恶性肿瘤发病率的影响：来自不良反应数据库的证据
Ryo Inose,Yuichi Muraki
Ryo Inose
Objective: Sodium-glucose cotransporter (SGLT) 2 inhibitors are expected to demonstrate secondary effects against malignancy. However, long-term and large-scale data are required to evaluate the effects of SGLT2 inhibitor...
Treatment of delayed fracture healing with Bushen Tiansui decoction: Analysis of active agents and targets using bioinformatics and network pharmacology analysis [0.03%]
补肾填髓汤治疗骨折延迟愈合的作用物质及靶点研究：基于生物信息学和网络药理学分析
Gao Wang,Ling Cheng,Zichen Shao et al.
Gao Wang et al.
Objective: This study aims to utilize bioinformatics and network pharmacology to identify the active components of Bushen Tiansui decoction (BSTSD) and elucidate its molecular mechanisms and targets in promoting delayed f...
Renoprotective effects of dulaglutide, a GLP-1 agonist, involving regulation of epithelial-mesenchymal transition in patients with type 2 diabetes and diabetic kidney disease [0.03%]
利拉鲁肽调节上皮间质转化作用对2型糖尿病合并糖尿病肾病患者的肾脏保护效应
Daoli Jiang,Fandong Meng,Xiaohua Chou et al.
Daoli Jiang et al.
Aims: To assess the renoprotective effects of dulaglutide and identify mechanisms of action in patients with type 2 diabetes and diabetic kidney disease (DKD). ...
María Rodríguez Jorge,Loreto Domínguez Senín,Stephanie Saide Cobelas Cartagena et al.
María Rodríguez Jorge et al.
Introduction: Sunitinib is an oral drug approved for the treatment of metastatic renal cell carcinoma. Serious cutaneous adverse reactions to sunitinib are rare, and when they occur, discontinuation of the treatment may b...
Evidence that anticoagulant use decreases in-hospital deaths in patients with new-onset atrial fibrillation [0.03%]
抗凝药物的使用可降低新发房颤患者住院死亡率的证据
Chun-Tse Hung,Yi-Jei Lin,Chi-Won Suk et al.
Chun-Tse Hung et al.
Objective: Current guidelines provide no clear recommendations for managing new-onset atrial fibrillation in critical illness, particularly with respect to anticoagulant use. This retrospective study aimed to evaluate the...
Sarcopenia with muscle wasting in hepatic cancer predicts therapeutic outcome after hepatic artery intervention [0.03%]
肝癌患者肌减少症与肌肉消耗预测动脉介入治疗预后的研究
Yuejuan Liao
Yuejuan Liao
Objectives: We aimed to study sarcopenia for its significance in predicting the effect of hepatic artery intervention (HAI) plus lenvatinib on hepatitis B-related hepatocellular carcinoma (HCC) complicated with diabetes m...
Medication reconciliation in intensive care units of a tertiary hospital in Saudi Arabia: An evaluation of medication discrepancies [0.03%]
沙特阿拉伯一家三级医院重症监护室中的药物治疗协调：评估药物差异
Samaher A Alatmi,Mohammad Aljawadi,Mansour Almuqbil et al.
Samaher A Alatmi et al.
Background: Patients discharged from intensive care units (ICUs) are at higher risk for medication discrepancies, which can harm patients, increase healthcare costs, and lead to readmission. This study aimed to describe t...
Antibiotic treatment of ceftriaxone-susceptible Serratia marcescens bacteremia: A multicenter, retrospective cohort study [0.03%]
头孢曲松敏感沙雷氏菌菌血症的抗生素治疗：一项多中心回顾性队列研究
Abdallah Mughrabi,Julian Maamari,Timothy Phillips et al.
Abdallah Mughrabi et al.
Background: Serratia marcescens has recently been categorized as low-risk for AmpC β-lactamase inducible production, but research on outcomes in Serratia bacteremia by antibiotic choice is limited. ...
Topics in focus 2025 The International Journal of Clinical Pharmacology and Therapeutics [0.03%]
焦点话题 2025年《临床药理与治疗杂志》
Barrington G Woodcock-Kloberdanz
Barrington G Woodcock-Kloberdanz